Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry

INTRODUCTION: Renin-angiotensin-system inhibitors (RASi) have shown survival benefits after acute myocardial infarction (MI), but the role of routine long-term use of RASi remains unclear. Thereby, we explored the therapeutic effects of RASi medication at 1-year follow-up from acute MI. METHODS: Usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chan Soon, Yang, Han-Mo, Kang, Jeehoon, Han, Jung-Kyu, Park, Kyung Woo, Kang, Hyun-Jae, Koo, Bon-Kwon, Seung, Ki-Bae, Cha, Kwang Soo, Seong, In-Whan, Rha, Seung-Woon, Jeong, Myung Ho, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471088/
https://www.ncbi.nlm.nih.gov/pubmed/36119742
http://dx.doi.org/10.3389/fcvm.2022.994419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471088/
https://www.ncbi.nlm.nih.gov/pubmed/36119742
http://dx.doi.org/10.3389/fcvm.2022.994419

Ejemplares similares